Related Experiment Video

Updated: Jun 4, 2026

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

Towards validated assays for key immunological outcomes in malaria vaccine development

, David R Cavanagh, Patrice M Dubois

    Vaccine
    |February 8, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
    10:38

    High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

    Published on: July 17, 2014

    Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
    09:57

    Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

    Published on: August 6, 2020

    Related Experiment Videos

    Last Updated: Jun 4, 2026

    An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
    08:14

    An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

    Published on: October 6, 2015

    High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
    10:38

    High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

    Published on: July 17, 2014

    Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
    09:57

    Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

    Published on: August 6, 2020

    Related Concept Videos

    Malaria01:29

    Malaria

    Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

    Articles linked to this work by shared authors, journal, and citation graph.

    Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite protein.

    NPJ vaccines·2026

    Structure and functional diversity of antibodies targeting the P. falciparum circumsporozoite protein C-terminal domain.

    bioRxiv : the preprint server for biology·2026

    Continental-scale genomic surveillance of Plasmodium falciparum malaria across sub-Saharan Africa with rapid nanopore sequencing.

    Nature communications·2026

    Relevance of the antibody Fc fragment and epitope valency in protection against malaria sporozoites.

    EMBO reports·2026

    Patients with Atopic Dermatitis and Insufficient Response to Conventional Systemic Therapy in Germany: A Health Claims Data Analysis.

    Dermatology and therapy·2026

    Cascading Disasters, Perinatal Wellbeing, and Infant Feeding Practices in South Alabama.

    New solutions : a journal of environmental and occupational health policy : NS·2026

    Ethiopia missed opportunities for vaccination study: Cluster-randomized evaluation of 5-dose measles vaccine vials and a flexible open-vial policy, 2021-2022.

    Vaccine·2026

    Human papillomavirus (HPV) Vaccination programmes across European countries: time-harmonized coverage among adolescent females, socioeconomic predictors, and impact on public interest.

    Vaccine·2026

    Wuhan-ancestral multi-antigen SARS-CoV-2 virus-like particles protect against the omicron sublineage JN.1 variant.

    Vaccine·2026

    Diphtheria in Switzerland, 1877-2022: long-term epidemiology and the impact of mid-20th-century vaccination programs.

    Vaccine·2026

    Cell culture-derived vaccine for rabbit haemorrhagic disease virus 2.

    Vaccine·2026

    AS04-adjuvanted semisynthetic glycoconjugate vaccine against Pseudomonas aeruginosa.

    Vaccine·2026

    Factors impacting protective immunity conferred by vaccination with adeno-associated virus-like particles displaying human papillomavirus L2 residues 17-36.

    Journal of virology·2026

    Time-Dependent Changes in YKL-40 and Inflammatory Markers in Experimental Acute Mesenteric Ischemia.

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026

    Fc-engineered broadly neutralizing antibodies overcome cytokine-induced CD16 cleavage to drive potent ADCC against diverse HIV-1 strains.

    mBio·2026

    Antibody-mediated SARS-CoV-2 entry and conformational regulation.

    Microbiology spectrum·2026

    Microbial and functional shifts between flare and remission in a single-center cohort of children with inflammatory bowel disease.

    World journal of clinical pediatrics·2026

    Molecular innate immune programs of tumor-associated macrophages in immune checkpoint blockade resistance: a staged framework from suppressive circuitry to translational bottlenecks.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us